Ingalls & Snyder LLC’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,574
Closed -$208K 438
2024
Q4
$208K Sell
1,574
-25
-2% -$3.3K 0.01% 392
2024
Q3
$233K Buy
+1,599
New +$233K 0.01% 381
2023
Q4
Sell
-2,530
Closed -$309K 432
2023
Q3
$309K Sell
2,530
-10
-0.4% -$1.22K 0.01% 325
2023
Q2
$322K Sell
2,540
-29
-1% -$3.68K 0.02% 331
2023
Q1
$332K Hold
2,569
0.02% 319
2022
Q4
$337K Sell
2,569
-15
-0.6% -$1.97K 0.02% 315
2022
Q3
$302K Hold
2,584
0.02% 322
2022
Q2
$304K Sell
2,584
-100
-4% -$11.8K 0.02% 326
2022
Q1
$350K Sell
2,684
-225
-8% -$29.3K 0.02% 326
2021
Q4
$444K Sell
2,909
-286
-9% -$43.7K 0.02% 309
2021
Q3
$517K Sell
3,195
-55
-2% -$8.9K 0.02% 286
2021
Q2
$532K Buy
3,250
+285
+10% +$46.7K 0.02% 290
2021
Q1
$446K Sell
2,965
-566
-16% -$85.1K 0.02% 298
2020
Q4
$535K Sell
3,531
-2,309
-40% -$350K 0.03% 268
2020
Q3
$791K Buy
5,840
+340
+6% +$46.1K 0.05% 199
2020
Q2
$752K Buy
5,500
+283
+5% +$38.7K 0.04% 214
2020
Q1
$562K Sell
5,217
-379
-7% -$40.8K 0.04% 244
2019
Q4
$674K Sell
5,596
-253
-4% -$30.5K 0.04% 231
2019
Q3
$582K Sell
5,849
-3,051
-34% -$304K 0.03% 264
2019
Q2
$971K Sell
8,900
-40
-0.4% -$4.36K 0.05% 223
2019
Q1
$999K Sell
8,940
-4,167
-32% -$466K 0.05% 218
2018
Q4
$1.26M Sell
13,107
-1,245
-9% -$120K 0.07% 185
2018
Q3
$1.75M Sell
14,352
-145
-1% -$17.7K 0.07% 180
2018
Q2
$1.59M Buy
14,497
+1,933
+15% +$212K 0.07% 167
2018
Q1
$1.34M Sell
12,564
-654
-5% -$69.8K 0.07% 178
2017
Q4
$1.41M Buy
13,218
+1,347
+11% +$144K 0.06% 178
2017
Q3
$1.32M Sell
11,871
-924
-7% -$103K 0.07% 164
2017
Q2
$1.32M Buy
12,795
+6,414
+101% +$663K 0.07% 164
2017
Q1
$624K Sell
6,381
-483
-7% -$47.2K 0.03% 234
2016
Q4
$607K Buy
6,864
+1,701
+33% +$150K 0.03% 232
2016
Q3
$498K Buy
5,163
+150
+3% +$14.5K 0.03% 243
2016
Q2
$430K Buy
+5,013
New +$430K 0.03% 263